Prognostic and Predictive Gene Signature for Adjuvant Chemotherapy in Resected Non–Small-Cell Lung Cancer
Top Cited Papers
- 11 October 2010
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 28 (29) , 4417-4424
- https://doi.org/10.1200/jco.2009.26.4325
Abstract
Purpose The JBR.10 trial demonstrated benefit from adjuvant cisplatin/vinorelbine (ACT) in early-stage non–small-cell lung cancer (NSCLC). We hypothesized that expression profiling may identify sta...This publication has 36 references indexed in Scilit:
- Prognostic gene signatures for non-small-cell lung cancerProceedings of the National Academy of Sciences, 2009
- Somatic mutations affect key pathways in lung adenocarcinomaNature, 2008
- Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation studyNature Medicine, 2008
- KEGG for linking genomes to life and the environmentNucleic Acids Research, 2007
- Characterizing the cancer genome in lung adenocarcinomaNature, 2007
- Survival prediction of stage I lung adenocarcinomas by expression of 10 genesJournal of Clinical Investigation, 2007
- Gene-expression profiles predict survival of patients with lung adenocarcinomaNature Medicine, 2002
- Regulation of p53 stability by Mdm2Nature, 1997
- Mdm2 promotes the rapid degradation of p53Nature, 1997
- Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53Nature, 1993